Beacon Investment Advisory Services Inc. Sells 137,722 Shares of Zoetis Inc. $ZTS

Beacon Investment Advisory Services Inc. decreased its position in shares of Zoetis Inc. (NYSE:ZTS) by 98.4% during the fourth quarter, HoldingsChannel reports. The firm owned 2,269 shares of the company’s stock after selling 137,722 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in Zoetis were worth $285,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in ZTS. Summit Place Financial Advisors LLC increased its position in shares of Zoetis by 0.4% during the 3rd quarter. Summit Place Financial Advisors LLC now owns 19,369 shares of the company’s stock valued at $2,834,000 after purchasing an additional 76 shares during the last quarter. First County Bank CT lifted its position in Zoetis by 5.4% in the 3rd quarter. First County Bank CT now owns 1,535 shares of the company’s stock worth $225,000 after buying an additional 79 shares during the last quarter. CWA Asset Management Group LLC lifted its position in Zoetis by 1.1% in the 3rd quarter. CWA Asset Management Group LLC now owns 7,236 shares of the company’s stock worth $1,059,000 after buying an additional 80 shares during the last quarter. Balefire LLC boosted its stake in Zoetis by 3.5% in the third quarter. Balefire LLC now owns 2,463 shares of the company’s stock worth $360,000 after buying an additional 84 shares in the last quarter. Finally, Evergreen Capital Management LLC boosted its stake in Zoetis by 3.3% in the third quarter. Evergreen Capital Management LLC now owns 2,696 shares of the company’s stock worth $394,000 after buying an additional 85 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on ZTS. The Goldman Sachs Group raised shares of Zoetis to a “buy” rating in a research note on Monday, December 15th. Piper Sandler reaffirmed a “neutral” rating and issued a $135.00 price objective (down from $190.00) on shares of Zoetis in a research note on Thursday, January 22nd. Bank of America increased their target price on shares of Zoetis from $135.00 to $140.00 and gave the company a “neutral” rating in a report on Friday, February 13th. UBS Group set a $136.00 target price on shares of Zoetis in a research report on Thursday, January 29th. Finally, William Blair reissued an “outperform” rating on shares of Zoetis in a research note on Monday, March 2nd. Six analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $152.91.

Zoetis Price Performance

Shares of Zoetis stock opened at $116.41 on Tuesday. The company has a debt-to-equity ratio of 2.71, a current ratio of 3.03 and a quick ratio of 1.94. Zoetis Inc. has a one year low of $113.29 and a one year high of $172.23. The business’s 50 day simple moving average is $123.23 and its two-hundred day simple moving average is $128.79. The stock has a market capitalization of $49.14 billion, a P/E ratio of 19.34, a price-to-earnings-growth ratio of 1.73 and a beta of 0.95.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. The firm had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The business’s revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Monday, April 20th. Zoetis’s dividend payout ratio is currently 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.